SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-029368
Filing Date
2023-08-18
Accepted
2023-08-18 06:02:21
Documents
48
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 935398
2 ex31-1.htm EX-31.1 10686
3 ex31-2.htm EX-31.2 10656
4 ex32-1.htm EX-32.1 7365
5 ex32-2.htm EX-32.2 4291
  Complete submission text file 0001493152-23-029368.txt   3984736

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE imun-20230630.xsd EX-101.SCH 31816
7 XBRL CALCULATION FILE imun-20230630_cal.xml EX-101.CAL 35232
8 XBRL DEFINITION FILE imun-20230630_def.xml EX-101.DEF 115777
9 XBRL LABEL FILE imun-20230630_lab.xml EX-101.LAB 238104
10 XBRL PRESENTATION FILE imun-20230630_pre.xml EX-101.PRE 181489
42 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 583711
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 231183709
SIC: 2834 Pharmaceutical Preparations